Viewing page 56 of 205

This transcription has been completed. Contact us with corrections.

"Comparative Study of Some Antifibrinolytic Agents and Proteinase Inhibitors" - T. Astrup, James F. Mitchell Foundation, Washington, D. C.

"Anticoagulant Effects of Trasylol: In Vitro and In Vivo Studies" - C. J. Amris and M. Hilden, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 

"Treatment of Fibrinolytic Hemorrhage with Proteinase Inhibitors" - J. L. Ambrus, Roswell Park Memorial Institute, Buffalo, N. Y.

"Role of Tissue Activator and Urokinase in Maintaining Bleeding and Treatment of Local Fibrinolysis with EACA and AMCA" - L. Andersson, I. M. Nilsson, B. Melander and B. Granstrand, University of Lund, Lund, Sweden.

"Comparative Activities of Proteinase Inhibitors on Natural and Synthetic Substrates" - A. Johnson, New York University, New York, N. Y. 

"Indications and Rationale for Use of Proteinase Inhibitors in Obstetric Conditions" F. K. Beller, New York University, New York, N. Y. 

"Treatment of Subarachnoidal and Other Intracranial Hemorrhages with Proteinase Inhibitors" - F. Sicuteri, University of Florence, Florence, Italy. 

12:30 P.M. - 
Luncheon

THROMBOSIS AND FIBRINOLYTIC HEMORRHAGE (CONT.)

Session Chairman: W. Lillehei
University of Minnesota 
Minneapolis, Minn. 

2:00 P.M. - 

"Experimental Investigations on the Antithromboplastic and Antifibrinolytic Activity of Trasylol" - B. Blombäck, M. Blombäck, S. Nordstöm, P. Olsson and E. Zetterqvist, Karolinska Institute, Stockholm, Sweden. 

"Effects of Proteinase Inhibitors on Blood Coagulation, Fibrinolysis, and Would Healing in Patients During and After Surgery" - P. Matis and F. K. Mörl, Chirurgische Universitäs-Klinik, Tübingen, Germany.